Spinal disc implant to be sold in Europe:
This article was originally published in Clinica
Executive Summary
RayMedica, a small US developer of devices to treat back pain, has CE-marked its PDN prosthetic disc nucleus devices and instrumentation. The Minneapolis, Minnesota-based company plans to launch the PDN implant in all EU countries after it has trained groups of surgeons in each country. Two of the devices, which are hydrogel cores covered with woven polyethylene, are implanted within the spinal disc of patients with low back pain, where they expand by absorbing fluid, taking pressure off the disc.
You may also be interested in...
Maxwellia Delivers Two UK Menstrual Health Rx-To-OTC Switches
UK switch specialist Maxwellia delivers two “me too” reclassifications in the area of women's health: Evana Heavy Period Relief and Ultravana Period Pain Relief.
WHO Examines Ethical Criteria For Human Challenge Trials Ahead Of Next Health Emergency
The World Health Organization is looking to finalize its guidance on the ethical criteria that should be applied to studies that involve deliberately infecting healthy individuals to speed up research.
Irish Body Sets Out Five-Year Vision Strategy For Off-Patent Sector
With a focus on drug accessibility, supply chain resilience, and a balanced approach to sustainability, Medicines for Ireland “calls to action” with its five-year plan.